Broadfin Capital Initiates Stake in Pernix Therapeutics (PTX)
Last night, Broadfin Capital, a healthcare focused hedge fund managed by Kevin Kotler, disclosed in a Securities and Exchange Commission filing that it has initiated a 3.5 million...
Posts Tagged ‘Hedge Fund:444’
Kevin Kotler’s Broadfin Capital Reports New Stake In MELA Sciences Inc (MELA)
Kevin Kotler’s Broadfin Capital, in its latest filing with the Securities and Exchange Commission, has reported ownership of 9.09 million shares of MELA Sciences Inc (NASDAQ...
Kevin Kotler’s Broadfin Capital Initiates Stake in Eleven Biotherapeutics (EBIO) Following Its IPO
Broadfin Capital, led by Kevin Kotler, in a filing with the Securities and Exchange Commission, reported initiating a position in Eleven Biotherapeutics, Inc. (NASDAQ:EBIO).
Broadfin Capital Initiates a Stake in Retrophin Inc (RTRX) Following Its Listing on NASDAQ
Kevin Kotler’s Broadfin Capital has revealed a new stake in Retrophin Inc (NASDAQ:RTRX), which amasses 6.93% of the company’s common stock, it contains 1.61 million shares...
Broadfin Capital Ups Position in Rigel Pharmaceuticals, Inc. (RIGL)
Kevin Kotler's Broadfin Capital increased its exposure to Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a filing with the SEC showed.
Kevin Kotler, Broadfin Capital Raise Holding in Derma Sciences Inc (DSCI)
Kevin Kotler's Broadfin Capital has increased its position in Derma Sciences Inc (NASDAQ:DSCI).
Broadfin Capital Boosts Stake in Horizon Pharma, Adds Alliqua to Its Equity Portfolio
In two newly amended filings with the SEC, Kevin Kotler's Broadfin Capital disclosed moves into Horizon Pharma Inc (NASDAQ:HZNP), and Alliqua Inc (OTCMKTS:ALQAD).
Kevin Kotler & Broadfin Capital Take a 5.2% Stake in Biodel
Biodel, Broadfin Capital: In a 13G filing reported a few minutes ago, Kevin Kotler's Broadfin Capital disclosed ownership of a 5.2% stake in Biodel Inc (NASDAQ:BIOD), a company...
Kevin Kotler’s Broadfin Capital Joins HealthCor in Idera
Broadfin Capital, Idera Pharmaceuticals: Just now, Kevin Kotler's Broadfin Capital disclosed adding Idera Pharmaceuticals Inc (NASDAQ:IDRA) to its equity portfolio in a filing...
Broadfin Capital Thinks CAS Medical Systems Inc (CASM) Is Worth Some Cash
Even though passive "hedgies" do not benefit from the same amount of coverage as their activist peers, their moves should also be watched closely.
Hedge Funds Are Selling Emergent Biosolutions Inc (EBS)
To many investors, hedge funds are viewed as delayed, outdated financial vehicles of a forgotten age.
Do Hedge Funds and Insiders Love Alere Inc (ALR)?
Now, according to many market players, hedge funds are assumed to be bloated, old investment tools of a period lost to current times.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is One of 5 Key Stocks in This Healthcare-Focused Hedgie’s Portfolio
Healthcare stocks aren’t for everyone, but one way average investors can learn more about this space is by paying attention to those who make a career out of it.
